Effects of Dapagliflozin on Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial

This randomized, open-label, two-arm, parallel-group trial enrolled patients with NAFLD and a controlled attenuation parameter.